Produkty 16910-32-0

CAS 16910-32-0 występuje w naszej ofercie pod nazwami: (+)-Obtusifoliol, Obtusifoliol, (+)-Obtusifoliol, 99%, 99%, Obtusifoliol, 99.86%, Obtusifoliol, 1 mg. Oferty producentów: TRC, GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 75mg, 10mg, 1mg, 5mg, 1 mg, 5 mg, 10 mg.

(+)-Obtusifoliol
TRC
  • opakowanie: 75mg
  • Warianty: 1
Zobacz produkt
Obtusifoliol
GLPBio, Biosynth
  • opakowanie: 10mg, 1mg
  • Warianty: 2
od 5848,56
Zobacz produkt
(+)-Obtusifoliol, 99%, 99%
Chemat
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 3294,80
Zobacz produkt
Obtusifoliol, 99.86%
MedChemExpress
  • opakowanie: 1 mg, 5 mg, 10 mg
  • Warianty: 3
od 1578,22
Zobacz produkt
Obtusifoliol, 1 mg
Roth
  • opakowanie: 1mg
  • Warianty: 1
od 750,42
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol (CAS 16910-32-0) to związek chemiczny o wzorze sumarycznym C30H50O i masie molowej 426.7 g/mol. Nazwa systematyczna IUPAC: (3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol. InChIKey: MMNYKQIDRZNIKT-VSADUBDNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H50O
Masa molowa426.7 g/mol
Nazwa IUPAC(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
InChIKeyMMNYKQIDRZNIKT-VSADUBDNSA-N
SMILESC[C@H]1[C@@H]2CCC3=C([C@]2(CC[C@@H]1O)C)CC[C@]4([C@]3(CC[C@@H]4[C@H](C)CCC(=C)C(C)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Obtusifoliol, (+)-OBTUSIFOLIOL, 4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol, 4alpha,14alpha-dimethyl-24-methylene-cholest-8-en-3beta-ol, 4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol, Ergosta-8,24(28)-dien-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-, Ergosta-8,24(28)-dien-3-ol, 4,14-dimethyl-, (3.beta.,4.alpha.,5.alpha.)-, orb1708992, MMNYKQIDRZNIKT-VSADUBDNSA-N, 5.alpha.-Ergosta-8,24(28)-dien-3.beta.-ol, 4.alpha.,14-dimethyl-
Izomery (ten sam wzór sumaryczny)
(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol C30H50O
(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol C30H50O
(3S,8R,9R,10S,13R,14S,17R)-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S)-2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(3S,4aR,6aR,6aR,6bR,8aR,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicen-3-ol C30H50O
(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol C30H50O
(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol C30H50O
2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1H-picen-3-one C30H50O
(3R,6aS,6aS,6bR,8aR,12aR,14aR,14bS)-4,4,6a,6b,8a,11,11,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-ol C30H50O
(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O